An experimental cancer drug made by Pfizer has shown signs of promise at slowing the spread of advanced breast cancer, researchers said. The drug, called palbociclib, when administered with another anti-cancer drug already on the market, letrozole,…
This site uses Akismet to reduce spam. Learn how your comment data is processed.